LMR Partners’s ResMed RMD Stock Holding History

LMR Partners’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$671K	Buy	+3,442	New	+$713K	﹤0.01%	1134
2026 Q1	–	Sell	-1,006	Closed	-$242K	–	1802
2025 Q4	$242K	Buy	1,006 +11	+1%	+$2.81K	﹤0.01%	1253
2025 Q3	$272K	Buy	+995	New	+$272K	﹤0.01%	1176
2024 Q4	–	Sell	-6,166	Closed	-$1.51M	–	1540
2024 Q3	$1.51M	Sell	6,166 -18,741	-75%	-$4.19M	0.01%	669
2024 Q2	$4.77M	Buy	+24,907	New	+$5.05M	0.04%	338
2021 Q3	–	Sell	-2,049	Closed	-$505K	–	1163
2021 Q2	$505K	Buy	+2,049	New	+$431K	0.01%	662
2020 Q4	–	Sell	-16,196	Closed	-$2.78M	–	607
2020 Q3	$2.78M	Buy	16,196 +212	+1%	+$39.1K	0.06%	130
2020 Q2	$3.07M	Buy	+15,984	New	+$2.62M	0.08%	181
2020 Q1	–	Sell	-3,194	Closed	-$495	–	413
2019 Q4	$495	Buy	+3,194	New	+$460K	﹤0.01%	301

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

LMR Partners's RMD Position: Q2 2026 in Review

LMR Partners opened a new position in ResMed (RMD) in Q2 2026: 3,442 shares worth $671K. The stake represents ﹤0.01% of the portfolio and ranks #1134 among its holdings. This is a return to the name: LMR Partners previously reported a position in RMD as recently as Q4 2025.

LMR Partners first reported a position in RMD in Q4 2019 and has held it in 9 quarters since. The position peaked at $4.77M in Q2 2024. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

LMR Partners held 3,442 shares of ResMed worth $671K as of Q2 2026.
ResMed was a new LMR Partners position in Q2 2026.
ResMed made up ﹤0.01% of LMR Partners's portfolio in Q2 2026, its #1134 holding.
LMR Partners first reported a position in ResMed in Q4 2019 and has held it in 9 quarters since.
LMR Partners's ResMed position peaked at $4.77M in Q2 2024.
882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.